retatrutide trial results Interesting data from the @EliLillyandCo phase 3 on Retatrutide Subcutaneous Fat Loss Results:

In the context of AD, the focus should be on individuals at risk, such as those with MCI, subjective cognitive decline, elders with positive A or tau biomarkers, APOE -4-carriers or healthy elderly individuals with high-risk scores [105]

However, promising trial results do not mean the drug is available for public use

Your body is going to be a little bit more protective of itself because we all need to have some level of fat on our bodies." This flared-up reaction towards hunger and calorie retention is the body's self-protection instincts kicking in

This article walks through what the clinical and mechanistic research actually shows about probiotics and GLP-1: how gut bacteria influence the hormone naturally, whether probiotics can meaningfully support people on GLP-1 medications, which strains have real evidence behind them, and how to think about fiber, timing, and safety

Extended breaks between cycles (at least 4 weeks) are mandatory for receptor resensitization

State-level regulations add another layer of complexity for US-based researchers